# Asacol Acute Diverticulitis(DIVA)Study

> **NCT00554099** · PHASE2 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 117 (actual)

## Conditions studied

- Diverticulitis

## Interventions

- **DRUG:** Mesalamine
- **DRUG:** Probiotic
- **DRUG:** Placebo
- **OTHER:** Dietary Advice
- **DRUG:** Antibiotic for Diverticulitis

## Key facts

- **NCT ID:** NCT00554099
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554099, "Asacol Acute Diverticulitis(DIVA)Study". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00554099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*